Pyxis Oncology, Inc.
USD2.86
+0.09 (+3.25%)
CEO
Thomas Civik
IPO Date
2021-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.70
Prev. Close
$2.77
Day Low
$2.62
Day High
$2.92
52W Low
$0.97
52W High
$5.55
Market Cap
$0.18B
Volume
1.23M
| 109,461 |
| $0.00 |
| 25 Mar 2026 | Wadhane Jitendra | Prin Fin & Acct Officer | A-Award | Acquired | 262,635 | $1.36 |
| 25 Mar 2026 | FLAVIN JOHN L | director | A-Award | Acquired | 45,867 | $1.36 |
| 25 Mar 2026 | Metzger Michael A | director | A-Award | Acquired | 45,867 | $1.36 |
| 25 Mar 2026 | Lewis-Hall Freda C | director | A-Award | Acquired | 45,867 | $1.36 |
| 25 Mar 2026 | Cline Darren S | director | A-Award | Acquired | 45,867 | $1.36 |
| 25 Mar 2026 | HUMPHREY RACHEL | director | A-Award | Acquired | 45,867 | $1.36 |
| 25 Mar 2026 | Palani Santhosh | director | A-Award | Acquired | 45,867 | $1.36 |
| 25 Mar 2026 | HUMPHREY RACHEL | director | S-Sale | Disposed | 1,400 | $0.97 |